Document is current
Any future updates will be listed below
-
Authors
Johnson, Kevin C. https://orcid.org/0000-0003-0016-5158
Spitzer, Avishay https://orcid.org/0000-0001-6551-9338
Varn, Frederick S. https://orcid.org/0000-0001-6307-016X
Nomura, Masashi https://orcid.org/0000-0001-6095-7849
Garofano, Luciano https://orcid.org/0000-0001-8582-0865
Chowdhury, Tamrin https://orcid.org/0000-0002-6747-6316
Lipsa, Anuja https://orcid.org/0000-0002-9668-6048
Zhang, Linbin
Fernández, Ester Calvo
Barak, Tanyeri
Gulhan Ercan-Sencicek, A. https://orcid.org/0000-0003-2838-3341
Peksen, Ayse Buket
Anderson, Kevin J. https://orcid.org/0000-0002-2362-273X
Tesileanu, C. Mircea S. https://orcid.org/0000-0003-3541-9242
Amin, Samirkumar B. https://orcid.org/0000-0002-3207-9505
Kocakavuk, Emre
Zhao, Dacheng
D’Angelo, Fulvio https://orcid.org/0000-0002-4940-4693
Migliozzi, Simona
Bussema, Lillian https://orcid.org/0000-0001-5469-3816
Gritsch, Simon
Moon, Hyo-Eun
Paek, Sun Ha https://orcid.org/0000-0003-3007-8653
Bielle, Franck https://orcid.org/0000-0001-6564-6388
Laurenge, Alice https://orcid.org/0000-0002-0058-3176
Di Stefano, Anna Luisa
Mathon, Bertrand https://orcid.org/0000-0002-9182-5846
Picca, Alberto
Sanson, Marc
Hau, Ann-Christin https://orcid.org/0000-0002-4412-2355
Hertel, Frank
Grzyb, Kamil
Zhao, Zheng https://orcid.org/0000-0001-8945-9632
Wang, Qianghu https://orcid.org/0000-0002-3488-1059
Jiang, Tao
Miller, Julie J.
Wakimoto, Hiroaki https://orcid.org/0000-0001-8225-241X
Cahill, Daniel P.
Moliterno, Jennifer
Günel, Murat https://orcid.org/0000-0002-2290-7055
Hermes, Beth
Sanai, Nader
Golebiewska, Anna https://orcid.org/0000-0002-4160-2521
Niclou, Simone P. https://orcid.org/0000-0002-3417-9534
Huse, Jason
Alfred Yung, W. K. https://orcid.org/0000-0002-1669-0793
Lasorella, Anna
Suvà, Mario L. https://orcid.org/0000-0001-9898-5351
Iavarone, Antonio https://orcid.org/0000-0002-0683-4634
Tirosh, Itay https://orcid.org/0000-0001-5477-2987
Verhaak, Roel G. W. https://orcid.org/0000-0003-2773-0436
- License Information
-
More Information
Article History
Received: 5 October 2024
Accepted: 30 April 2026
First Online: 3 June 2026
Competing interests
: M.L.S. is an equity holder, scientific co-founder and advisory board member of Immunitas Therapeutics. I.T. is an advisory board member of Immunitas Therapeutics and is a co-founder and scientific advisor of Cellyrix Therapeutics. R.G.W.V. is a co-founder of and holds equity in Boundless Bio. F.B. has a next-of-kin employed by Bristol Myers Squibb. D.P.C. has received financial compensation from Boston Scientific (2025) and Servier (2023) for advisory input. He has also received financial compensation and travel reimbursement from the US NIH and DOD for clinical trial and grant review (2024). J.J.M. receives consulting fees from Servier. The authors declare that such activities have no relationship to the current study.
